These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 29587243)

  • 1. Serum calcium levels and neuropsychological performance in depression and matched healthy controls: Reversal of correlation a marker of the aging cognitive clock?
    Grützner TM; Listunova L; Fabian GA; Kramer BA; Flach D; Weisbrod M; Roesch-Ely D; Sharma A
    Psychoneuroendocrinology; 2018 May; 91():198-205. PubMed ID: 29587243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between serum calcium and neuropsychological performance might indicate etiological heterogeneity underlying cognitive deficits in schizophrenia and depression.
    Sharma A; Schray A; Bartolovic M; Roesch-Ely D; Aschenbrenner S; Weisbrod M
    Psychiatry Res; 2017 Jun; 252():80-86. PubMed ID: 28259035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta-amyloid deposition and cognitive function in patients with major depressive disorder with different subtypes of mild cognitive impairment: (18)F-florbetapir (AV-45/Amyvid) PET study.
    Wu KY; Liu CY; Chen CS; Chen CH; Hsiao IT; Hsieh CJ; Lee CP; Yen TC; Lin KJ
    Eur J Nucl Med Mol Imaging; 2016 Jun; 43(6):1067-76. PubMed ID: 26739329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurocognitive performance in patients with depression compared to healthy controls: Association of clinical variables and remission state.
    Grützner TM; Sharma A; Listunova L; Bartolovic M; Weisbrod M; Roesch-Ely D
    Psychiatry Res; 2019 Jan; 271():343-350. PubMed ID: 30529317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypothalamic-pituitary-adrenal axis activity and cognition in major depression: The role of remission status.
    Salvat-Pujol N; Labad J; Urretavizcaya M; de Arriba-Arnau A; Segalàs C; Real E; Ferrer A; Crespo JM; Jiménez-Murcia S; Soriano-Mas C; Menchón JM; Soria V
    Psychoneuroendocrinology; 2017 Feb; 76():38-48. PubMed ID: 27883963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropsychiatric and cognitive features of major depressive disorder in aging, based on the data from the US National Alzheimer's Coordinating Center (NACC).
    Ronat L; Hanganu A
    Encephale; 2024 Apr; 50(2):130-136. PubMed ID: 37088582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comorbid anxiety increases cognitive control activation in Major Depressive Disorder.
    Crane NA; Jenkins LM; Dion C; Meyers KK; Weldon AL; Gabriel LB; Walker SJ; Hsu DT; Noll DC; Klumpp H; Phan KL; Zubieta JK; Langenecker SA
    Depress Anxiety; 2016 Oct; 33(10):967-977. PubMed ID: 27454009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multidimensional cognitive impairment in unipolar and bipolar depression and the moderator effect of adverse childhood experiences.
    Poletti S; Aggio V; Brioschi S; Dallaspezia S; Colombo C; Benedetti F
    Psychiatry Clin Neurosci; 2017 May; 71(5):309-317. PubMed ID: 28004481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered fractional amplitude of low frequency fluctuation associated with cognitive dysfunction in first-episode drug-naïve major depressive disorder patients.
    Huang M; Lu S; Yu L; Li L; Zhang P; Hu J; Zhou W; Hu S; Wei N; Huang J; Weng J; Xu Y
    BMC Psychiatry; 2017 Jan; 17(1):11. PubMed ID: 28077120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of cognitive impairment in psychosocial functioning in remitted depression.
    Knight MJ; Air T; Baune BT
    J Affect Disord; 2018 Aug; 235():129-134. PubMed ID: 29655074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Childhood maltreatment and cognitive functioning in patients with major depressive disorder: a CAN-BIND-1 report.
    Chakrabarty T; Harkness KL; McInerney SJ; Quilty LC; Milev RV; Kennedy SH; Frey BN; MacQueen GM; Müller DJ; Rotzinger S; Uher R; Lam RW
    Psychol Med; 2020 Nov; 50(15):2536-2547. PubMed ID: 31583989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pain and major depressive disorder: Associations with cognitive impairment as measured by the THINC-integrated tool (THINC-it).
    Cha DS; Carmona NE; Mansur RB; Lee Y; Park HJ; Rodrigues NB; Subramaniapillai M; Rosenblat JD; Pan Z; Lee JH; Lee J; Almatham F; Alageel A; Shekotikhina M; Zhou AJ; Rong C; Harrison J; McIntyre RS
    Scand J Pain; 2017 Apr; 15():62-67. PubMed ID: 28850348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated triglyceride levels are associated with cognitive impairments among patients with major depressive disorder.
    Shao TN; Yin GZ; Yin XL; Wu JQ; Du XD; Zhu HL; Liu JH; Wang XQ; Xu DW; Tang WJ; Hui L
    Compr Psychiatry; 2017 May; 75():103-109. PubMed ID: 28342378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between immunometabolic status and cognitive performance among major depression disorder patients.
    Sánchez-Carro Y; de la Torre-Luque A; Portella MJ; Leal-Leturia I; Salvat-Pujol N; Massaneda C; de Arriba-Arnau A; Urretavizcaya M; Peretó M; Toll A; Martínez-Ruiz A; Ferreiros-Martinez R; Álvarez P; Soria V; López-García P
    Psychoneuroendocrinology; 2022 Mar; 137():105631. PubMed ID: 34929555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of schooling and age on cognitive performance in healthy older adults.
    Bento-Torres NV; Bento-Torres J; Tomás AM; Costa VO; Corrêa PG; Costa CN; Jardim NY; Picanço-Diniz CW
    Braz J Med Biol Res; 2017 Mar; 50(4):e5892. PubMed ID: 28355353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive and emotional biomarkers of melancholic depression: An iSPOT-D report.
    Day CV; Gatt JM; Etkin A; DeBattista C; Schatzberg AF; Williams LM
    J Affect Disord; 2015 May; 176():141-50. PubMed ID: 25710095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance on the Wisconsin card-sorting test and serum levels of glial cell line-derived neurotrophic factor in patients with major depressive disorder.
    Zhang X; Ru B; Sha W; Xin W; Zhou H; Zhang Y
    Asia Pac Psychiatry; 2014 Sep; 6(3):302-7. PubMed ID: 24436216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive impairment as measured by the THINC-integrated tool (THINC-it): Association with psychosocial function in major depressive disorder.
    Cha DS; Carmona NE; Subramaniapillai M; Mansur RB; Lee Y; Hon Lee J; Lee J; Rosenblat JD; Shekotikhina M; Park C; Rong C; Greer TL; Lam R; Baune BT; Harrison J; McIntyre RS
    J Affect Disord; 2017 Nov; 222():14-20. PubMed ID: 28667888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Virtual reality working memory training improves cognitive performance of acute and remitted patients with major depressive disorder.
    Yan S; Shen S; Lu Q; Zhong S; Lv S; Lai S; Luo Y; Ran H; Duan M; Song K; Ye K; Jia Y
    J Affect Disord; 2024 Jan; 344():267-276. PubMed ID: 37838265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age at illness onset and physical activity are associated with cognitive impairment in patients with current diagnosis of major depressive disorder.
    Sánchez-Carro Y; Portella MJ; Leal-Leturia I; Salvat-Pujol N; Etxandi M; de Arriba-Arnau A; Urretavizcaya M; Pousa E; Toll A; Álvarez P; Soria V; López-García P
    J Affect Disord; 2021 Jan; 279():343-352. PubMed ID: 33099048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.